Virbagen Omega blev desuden undersøgt til behandling af infektion med FeLV og/ eller FIV hos over 9 uger gamle katte med eller uden anæmi.
The main measure of effectiveness was the mortality rate compared with cats that had not been treated and clinical signs after treatment.